SIV's natural hosts reveal how humans might better manage HIV infection

March 8, 2012, Emory University

Some monkeys can survive infection by SIV, a relative of HIV, and not develop AIDS. Their immune systems appear to display a pattern of "peaceful coexistence" rather than the all-out conflict provoked by HIV when it infects humans.

SIV's natural hosts are non-human primates found in , including sooty mangabeys and African green monkeys – both species whose infections have been studied in captivity -- as well as other species such as mandrills, drills and suntailed monkeys.

Since SIV's natural hosts have adapted to manage infection rather than fight and lose, we have much to learn from them, a team of scientists from Yerkes National Primate Research Center propose in an article published this week in Science.

Studying how SIV and its natural hosts co-exist could show medical researchers how to improve long-term care for people infected with and reduce mother-to-infant transmission, as well as guide the development of an AIDS vaccine, the researchers write.

The authors include Ann Chahroudi, Steven Bosinger, Thomas Vanderford, Mirko Paiardini and Guido Silvestri. Silvestri is chief of microbiology and immunology at Yerkes and a Georgia Research Alliance Eminent Scholar.

Together with NIH researcher Nichole Klatt, Silvestri is also author of a recent Perspective piece in Science Translational Medicine about the role of CD4+ T cells in HIV infection.

In their review, the scientists call SIV's natural hosts "the door through which HIV came to humans." Genetic analysis has shown that HIV infection of humans arose through multiple cross-species transmissions of SIV from non-human primates.

Distinctive features of SIV natural host infection include a low level of immune activation and a low rate of mother-to-infant transmission, compared to humans. This reflects evolutionary history during the last several thousand years, the authors propose.

"In this view, the genetic features of natural SIV hosts that underlie two key mechanisms of resistance (i.e. low immune activation and target cell restriction) may at least partially reflect evolutionary selection to protect from mother-to-infant transmission," they write.

Researchers have observed that a small number of HIV-infected people exhibit a "natural host-like" phenotype, where low levels of immune activation are seen. In most humans, HIV infection leads to chronic immune activation, which causes health problems even in people who receive long-term antiretroviral treatment.

During infection, SIV's natural hosts also manage to preserve particular types of immune cells including Th17 cells, which help maintain the intestines, and central memory T cells, important for keeping the immune system's ability to respond to previously encountered bacteria or viruses.

Understanding how SIV's natural hosts avoid chronic and preserve immune function could help improve medical care for people living with HIV , the authors conclude.

Explore further: Monkeys resist infection by closing gates that SIV, HIV use to get into cells

Related Stories

Monkeys resist infection by closing gates that SIV, HIV use to get into cells

June 26, 2011
Sooty mangabeys, a type of African monkey, have intrigued scientists for years because they can survive infection by SIV, a relative of HIV, and not succumb to AIDS.

Antibodies help protect monkeys from HIV-like virus, scientists show

May 5, 2011
Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.